1. Halsted WS. The results of operations for the cure of cancer the breast performed at the John Hopkins Hospital from June 1989 to January 1994, John Hopkins Hospital Hosp Bull. 1994¬1995:4:297-323.
2. Haris JR, Hellman S. Natural history of breast cancer. In: Haris JR, Lippman ME, Morrow M, et.al, eds. Diseases of the Breast. Philadelphia: Lippincott-Raven:1996.
3. Cascinelli N, Greco M, Bufalino R, Clemente C, Galluzzo D, Delle Done V, de Lellis R, Sacchini V, Veronesi U. Prognosis of breast cancer with axillary node metastasis after surgical treatment only. Eur J Cancer Clin Oncol 1987;23:795-799.
4. Siegel BM, Mayzel KA, Love Sm. Level 1 and 2 axillary dissection in the treatment of early stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 1990;125:1144-1147.
5. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-320.
6. Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight D, Winer EP Complications of axillary lymph node dissection for carcinoma of the breast. Cancer 1998;83:1362-1368.
7. Dixon M. Sentinel node biopsy in breast cancer. A promising technique, but it should not be introduced without proper trials. BMJ 1998;317(7145):295-296.
8. De Cicco D, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, Galimberti V, Calza P Viale G, Veronesi U, Paganelli G. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998;39:2080-2084.
9. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997;349:1668-1669.
10. Uren RF Howman-Gilers RB, Thompson JF Malouf D, Ramsey- Stewart G, Niesche FW, Renwick SB. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775-1780.
11. Ege GN. Lymphoscintigraphy, techniques and application in the management of breast cancer. Semin Nucl Med 1983;13:26-34.
12. Kaptejin BA, Nieweg OE, Petersen JL, Rutgers EJ, Hart AA, Van Dongen JA, Kroon BB. Identification and biopsy of the sentinel node in breast cancer. Eur J Surg Oncol 1998;24:427-430.
13. Krag DN, Weaver DL, Alex JC, Fairbank JT Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-339.
14. Borgstein PJ, Pijpers R, Comans EF, Van Diest PJ, Boom RP Meijer
S. Sentinel Lymph node in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-283.
15. Wong SL, Edwards MJ, Chao C,Tuttle TM, Noves RD, Carlson DJ, Laidley AL, Mc Glothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, McMasters KM, University of Louisville Breast Cancer Study Group. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 2002;9:272-277.
16. Haigh PI, Hansen NM, Qi K, Giuliano AE. Biopsy Method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000;7:21-27.
17. Van Wessem KJ, Meijer WS. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow up of sentinel lymph node negative patients. Breast 2004;13:290-296.
18. Sanlı Y, Berberoglu K, Turkmen C, Ozmen V, Muslumanoglu M, Igci A, Asoglu O, Kecer M, Tuzlali S, Cantez S, Mudun A. The Value of compined peritumoral and subdermal injection techniques for lymphoscintigraphy in detection of sentinel lymph node in breast cancer. Clin Nucl Med 2006;31:690-693.
19. Luini A, Galimberti V, Gatti G, Arnone P Vento AR, Trifiro G, Viale G, Rotmensz N, Fernandez JR, Gilardi D, Paganelli G. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat 2005;89:159-163.
20. Pijpers R, Mejler S, Hoekstra OS, Collet GJ, Comans EF, Boom RP Van Diest PJ, Teule GJ. Impact of lymphoscintigraphy on sentinel lymph node identification with technetium 99m colloidal albumin in breast cancer. J Nucl Med 1997;38:366-368.
21. Buscombe J, Paganelli G, Burak ZE, Waddington W, Maublant JM, Prats E, Palmedo H, Schillaci O, Maffioli L, Lassmann M, Chiesa C, Bombardieri E, Chiti A; European Association of Nuclear Medicine Oncology Committee and Dosimetry Committee. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007;34:2154-2159.
22. Lin KM, Patel TH, Ray A, Ota M, Jacobs L, Kuvshinoff B, Chung M, Watson M, Ota DM. Intradermal radioisotopes superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. J Am Coll Surg 2004;199:561-566.
23. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, Bernik S, Mills C, WAllack M, Abdel-Dayem HM. Retrospective analysis of sentinel node localization in multifocal multicentric, palpable, or non palpable breast cancer. J Nucl Med 2003;44:7-10.